NCT00002198View on ClinicalTrials.gov

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate

Trial Locations (1)

28412

PPD Development, Inc, Wilmington

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002198 - A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients | Biotech Hunter | Biotech Hunter